Ignite Creation Date:
2024-10-25 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06533189
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Protocol a Pilot Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Developing a Whole-body Magnetic Resonance Imaging and Diffusion-weighted Imaging State-of-the-art Protocol a Pilot Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
WANDA
Brief Summary:
Whole-body magnetic resonance imaging WB-MRI is a non-ionizing imaging method that can provide WB coverage using essential imaging contrasts with the possibility to include sequences focusing in specific body-regions as needed per case WB-MRI is increasingly being used for the management of cancer patients especially metastatic ones An integral part of WB-MRI is becoming whole-body diffusion-weighted MRI WB-DWI which is a non-invasive tool used for staging and response evaluation in oncologic practice WB-DWI is an inherently noisy technique resulting in it accounting for more than 50 of the acquisition time of conventional whole-body MRI studies with overall duration at least 1-hour Reducing acquisition times without compromising image or diagnostic quality would facilitate the wider adoption of clinical WBDWI reducing costs and improving the patient experience
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None